SCHEMBL9987901

SCHEMBL9987901

Oc1cccc(-c2[c]cccc2O)c1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HSD17B1 P14061 14/20 0.48
HSD17B2 P37059 13/20 0.48
CYP3A4 P08684 3/20 0.48
CYP2C9 P11712 2/20 0.48
ESR1 P03372 3/20 0.44
ESR2 Q92731 3/20 0.44
CYP1A2 P05177 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2B6 P20813 1/20 0.41
CYP2C19 P33261 1/20 0.41
CA12 O43570 1/20 0.41
ALDH1A1 P00352 1/20 0.41
CA2 P00918 1/20 0.41
LMNA P02545 1/20 0.41
CA5A P35218 1/20 0.41
CA9 Q16790 1/20 0.41
HSD17B10 Q99714 1/20 0.41
CA14 Q9ULX7 1/20 0.41
CA5B Q9Y2D0 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16720373 0.81 ACHE (0.41) CYP1A2CYP2C19
SCHEMBL9769410 0.81 HSD17B1 (0.45) HSD17B1HSD17B2CYP3A4CYP2C9ESR1
SCHEMBL16720131 0.81 ESR2 (0.47) HSD17B1HSD17B2ESR2LMNA
SCHEMBL4275387 0.81 HSD17B1 (0.47) HSD17B1HSD17B2CYP3A4CYP2C9ESR1
SCHEMBL16719910 0.81 ALOX5 (0.55) ESR2
SCHEMBL6607387 0.79 ALDH1A1 (0.46) CYP3A4ESR2CA12ALDH1A1CA2
SCHEMBL16719805 0.79 ACMSD (0.45) HSD17B1HSD17B2
SCHEMBL16720242 0.79 HSD17B1 (0.42) HSD17B1HSD17B2CYP3A4CYP2C9ESR1
SCHEMBL16719695 0.78 HSD17B1 (0.42) HSD17B1HSD17B2CYP3A4CA12ALDH1A1
SCHEMBL9987990 0.78 ESR1 (0.42) HSD17B1HSD17B2CYP3A4ESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2397462-A2 Compounds, compositions and methods of treatment for heart failure Cytokinetics, Inc. (US) 2011-12-21 EP claimed
EP-3068758-A1 EBNA1 INHIBITORS AND THEIR METHOD OF USE The Wistar Institute Of Anatomy And Biology (US) 2016-09-21 EP disclosed
WO-2015073864-A1 EBNA1 INHIBITORS AND THEIR METHOD OF USE THE WISAR INSTITUTE OF ANATOMY AND BIOLOGY (US) 2015-05-21 WO disclosed